Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive … Read more
Market Cap & Net Worth: Viemed Healthcare Inc (VMD)
Viemed Healthcare Inc (NASDAQ:VMD) has a market capitalization of $368.39 Million ($368.39 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13038 globally and #5474 in its home market, demonstrating a 4.31% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Viemed Healthcare Inc's stock price $9.69 by its total outstanding shares 38017907 (38.02 Million).
Viemed Healthcare Inc Market Cap History: 2018 to 2026
Viemed Healthcare Inc's market capitalization history from 2018 to 2026. Data shows growth from $144.47 Million to $368.39 Million (22.83% CAGR).
Index Memberships
Viemed Healthcare Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #355 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1274 of 3165 |
Weight: Viemed Healthcare Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Viemed Healthcare Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Viemed Healthcare Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.36x
Viemed Healthcare Inc's market cap is 1.36 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
27.07x
Viemed Healthcare Inc's market cap is 27.07 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $144.47 Million | $65.27 Million | $10.18 Million | 2.21x | 14.20x |
| 2019 | $235.71 Million | $80.26 Million | $8.53 Million | 2.94x | 27.65x |
| 2020 | $295.02 Million | $131.31 Million | $31.53 Million | 2.25x | 9.36x |
| 2021 | $198.45 Million | $117.06 Million | $9.13 Million | 1.70x | 21.75x |
| 2022 | $287.42 Million | $138.83 Million | $6.22 Million | 2.07x | 46.19x |
| 2023 | $298.44 Million | $183.01 Million | $10.24 Million | 1.63x | 29.14x |
| 2024 | $304.90 Million | $224.26 Million | $11.27 Million | 1.36x | 27.07x |
Competitor Companies of VMD by Market Capitalization
Companies near Viemed Healthcare Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Viemed Healthcare Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Viemed Healthcare Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Viemed Healthcare Inc's market cap moved from $144.47 Million to $ 368.39 Million, with a yearly change of 22.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $368.39 Million | +30.42% |
| 2025 | $282.47 Million | -7.36% |
| 2024 | $304.90 Million | +2.17% |
| 2023 | $298.44 Million | +3.84% |
| 2022 | $287.42 Million | +44.83% |
| 2021 | $198.45 Million | -32.73% |
| 2020 | $295.02 Million | +25.16% |
| 2019 | $235.71 Million | +63.16% |
| 2018 | $144.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Viemed Healthcare Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $368.39 Million USD |
| MoneyControl | $368.39 Million USD |
| MarketWatch | $368.39 Million USD |
| marketcap.company | $368.39 Million USD |
| Reuters | $368.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.